Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage Patient Counseling Information MIMS Class ATC Classification Regulatory Classification Presentation/Packing

The information highlighted (if any) are the most recent updates for this brand.

Full Prescribing Info

Indications/Uses

Asthma: Symbicort Turbuhaler is indicated for the treatment of asthma, to achieve overall asthma control, including the relief of symptoms and the reduction of the risk of exacerbations (see Dosage & Administration).
Note: Symbicort (80/4.5 micrograms/inhalation) is not appropriate in patients with severe asthma.
Chronic Obstructive Pulmonary Disease (COPD): Symbicort Turbuhaler is indicated in adults, aged 18 years and older, for the symptomatic treatment of patients with COPD with FEV₁ < 70% predicted normal (post bronchodilator) and an exacerbation history despite regular bronchodilator therapy.

Symbicort Turbuhaler Indications/Uses

budesonide + formoterol

Manufacturer:

AstraZeneca

Distributor:

Zuellig Pharma